The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

La protección del genoma es esencial para el correcto funcionamiento de las células y, lo que es más importante, para aplicaciones seguras y eficaces que impliquen células madre pluripotentes y ...

加州再生医学研究所独立公民监督委员会定期会议治理小组委员会。 根据加利福尼亚州干细胞研究与治疗法案组织。 将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

在常染色体显性多囊肾病 (ADPKD) 中发现了 DNA 甲基化异常，这表明甲基化组是一个有前途的治疗靶点。然而，DNA 甲基化抑制剂 (DNMTi) 和 ADPKD 药物联合治疗 ADPKD 以及对疾病相关甲基化模式的影响 ...